Put Options Transactions Made in Q4 2024 in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX) during Q4 2024. The information is specifically focused on institutions that hold put options of Celldex Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
PUT |
-19.7K- 42.37% |
$459K - $638K
|
26.8K
$602K
|
|
|
Feb 14, 2025
Q4 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
PUT |
-29.3K- 32.48% |
$683K - $949K
|
60.9K
$1.37M
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
PUT |
-37.9K- 15.56% |
$883K - $1.23M
|
206K
$4.62M
|
|
|
Feb 14, 2025
Q4 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
PUT |
-50.6K- 47.74% |
$1.18M - $1.64M
|
55.4K
$1.24M
|
|
|
Feb 14, 2025
Q4 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
PUT |
-100K- 32.73% |
$2.33M - $3.24M
|
206K
$4.62M
|